Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Conducting Root Cause Analysis for Product Failures – V 2.0

Posted on By

Creams: SOP for Conducting Root Cause Analysis for Product Failures – V 2.0

Standard Operating Procedure for Conducting Root Cause Analysis for Product Failures

Department Creams
SOP No. SOP/CRM/189/2025
Supersedes SOP/CRM/189/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to provide a structured approach for conducting Root Cause Analysis (RCA) for product failures in the cream manufacturing process. The goal is to identify the underlying causes of product defects or failures and implement corrective actions to prevent recurrence, ensuring consistent product quality.

2. Scope

This SOP applies to all instances of product failures in the cream manufacturing process. It covers the identification, investigation, and resolution of issues related to product defects, quality control failures, or deviations from product specifications.

3. Responsibilities

  • Production Team: Responsible for providing all relevant production data, assisting in the investigation, and implementing corrective actions based on the root cause analysis.
  • Quality Control (QC) Team: Responsible for identifying product failures, conducting initial inspections, and collaborating in the root cause analysis process.
  • Quality Assurance (QA) Team: Responsible for leading the root cause analysis process, ensuring thorough investigation, and ensuring that corrective actions are taken. The QA team
also ensures compliance with GMP guidelines throughout the process.
  • Regulatory Affairs Team: Responsible for ensuring that the root cause analysis and corrective actions comply with regulatory requirements and communicating with regulatory bodies if necessary.
  • 4. Accountability

    The QA Manager is accountable for overseeing the Root Cause Analysis process, ensuring proper investigation, and implementation of corrective actions. The Production Manager is responsible for providing support during the investigation and ensuring that corrective actions are implemented. The QC Manager is responsible for assisting in identifying product failures and supporting the investigation.

    5. Procedure

    5.1 Identification of Product Failure

    1. Product failures may be identified through various sources, such as:
      • QC testing (e.g., product not meeting specifications)
      • Customer complaints
      • Deviations from product specifications during production
      • Internal audits or inspections
    2. Once a failure is identified, the production team must notify the QA team immediately, documenting the failure in the Non-Conformance Report (Annexure-1).
    3. The QA team will review the initial data and determine if a Root Cause Analysis is needed.

    5.2 Root Cause Investigation

    1. The QA team leads the root cause investigation. The investigation should be comprehensive, examining all possible factors that could have contributed to the failure, including:
      • Raw materials
      • Equipment malfunction
      • Process deviations
      • Human error or lack of training
      • Environmental factors
    2. The team will collect all relevant data, including production records, equipment logs, test results, and staff training records.
    3. All team members will collaborate to identify the most likely root causes and rule out other possible factors.
    4. The investigation should use tools like the 5 Whys technique, Fishbone diagram, or Failure Mode and Effect Analysis (FMEA) to systematically identify the root cause.

    5.3 Root Cause Identification and Documentation

    1. Once the root cause is identified, it should be documented in the Root Cause Analysis Report (Annexure-2), including:
      • A description of the issue
      • Steps taken during the investigation
      • Root cause(s) identified
      • Evidence or data supporting the root cause
    2. All findings must be verified by the QA team and signed off by the Production Manager and QC Manager to confirm accuracy and completeness.

    5.4 Corrective and Preventive Action Plan (CAPA)

    1. Based on the findings of the root cause analysis, the team will develop a Corrective and Preventive Action (CAPA) plan. The CAPA plan must address:
      • The corrective actions needed to resolve the issue immediately
      • The preventive actions to ensure the issue does not recur in the future
      • A timeline for implementing the corrective and preventive actions
      • The person responsible for each action
    2. The CAPA plan should be documented and reviewed by the QA Manager before being finalized.
    3. The corrective actions should be implemented as soon as possible, and preventive actions should be scheduled for long-term implementation.

    5.5 Monitoring and Verification of Corrective Actions

    1. After the CAPA plan is implemented, the QA team will monitor the effectiveness of the corrective and preventive actions.
    2. Follow-up audits or inspections should be scheduled to verify that the actions taken have effectively addressed the root cause and prevented recurrence of the failure.
    3. If the corrective actions do not prove effective, the root cause analysis process should be revisited to identify additional or alternate actions.

    5.6 Documentation and Record-Keeping

    1. All documentation related to the root cause analysis, including the investigation report, CAPA plan, and follow-up verification records, must be retained according to GMP guidelines.
    2. Records should be stored in a secure, controlled document management system to ensure that they are accessible for future reference or audits.
    3. All records must be retained for at least two years or as specified by regulatory agencies.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QA: Quality Assurance
    • QC: Quality Control
    • SOP: Standard Operating Procedure
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Annexure-1: Non-Conformance Report
    2. Annexure-2: Root Cause Analysis Report
    3. Annexure-3: CAPA Plan

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Root Cause Analysis and CAPA

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Non-Conformance Report

    Issue Description Product Affected Batch Number Detected By Date Detected
    Viscosity Out of Specification Vanilla Cream Batch 12345 QC Inspector 21/01/2026

    Annexure-2: Root Cause Analysis Report

    Root Cause Contributing Factors Corrective Actions Preventive Actions
    Incorrect mixing time Equipment malfunction, Operator error Repair equipment, retrain operators Implement double-check system for mixing time

    Annexure-3: CAPA Plan

    Corrective Action Preventive Action Responsible Person Implementation Date
    Fix mixing time settings on equipment Train operators on mixing procedures Production Manager 28/01/2026

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Yield Calculation in Cream Manufacturing - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: Biosimilars: SOP for Emergency Shutdown of Bioreactor – V 2.0
    Next Post: Analytical Method Development: Identification of Process Related Impurities – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version